Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

It was interesting to hear the analyst's expression of the concerns of the investment community, that was the key to the conversation and occurred almost at the end. Helen was fine, but being nice and perky doesn't hide the structural problems.

Of those "concerns", the one you didn't mention was the skepticism on whether HALO can pull off a deal that adds to the income stream without over-paying for it. I've said so myself many times that the purchase of another company by HALo will not be good for the HALO price per share, and the Goldman guy implied as much.

He also suggested that Helen has painted herself into a corner by announcing the intention to make an acquisition. She's got to deliver now, but is faced with a universe in which any promising target will likely be very expensive. This is not a good position to be in and that is why the pps is down in the dumps after the refi. This is not me talking trash, this is just a repetition of what the Goldman guy was pointing towards as problems in the road ahead.

I have not seen any evidence of upgrades and don't expect any. HALO bounced today on low volume after being pretty oversold technically.

-Fritz